高级检索
当前位置: 首页 > 详情页

Molecular and transcriptional basis of bidirectional CD4+ T cell exhaustion in oropharyngeal squamous cell carcinoma

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Oto-Rhino-Laryngology West China Hospital, Sichuan University Chengdu Sichuan China. [2]Research Core Facility West China Hospital Sichuan University Chengdu China. [3]Institute of Clinical Pathology West China Hospital Sichuan University Chengdu Sichuan China. [4]West China Biomedical Big Data Center West China Hospital Sichuan University Chengdu Sichuan China.
出处:

关键词: CD4-positive T-lymphocytes head and neck cancer immune checkpoint inhibitors T cell exhaustion tumor microenvironment

摘要:
Tumor-infiltrating CD4+ T cells orchestrate the adaptive immune response through remarkable plasticity, and the expression patterns of exhaustion-related inhibitory receptors in these cells differ significantly from those of CD8+ T cells. Thus, a better understanding of the molecular basis of CD4+ T cell exhaustion and their responses to immune checkpoint blockade (ICB) is required. Here, we integrated multiomics approaches to define the phenotypic and molecular profiles of exhausted CD4+ T cells in oropharyngeal squamous cell carcinoma (OPSCC). Two distinct immune-promoting (Module 1) and immunosuppressive (Module 2) functional modules in tumor-infiltrating CD4+ T cells were identified, and both the immune-promoting function of Module 1 cells and immunosuppressive function of Module 2 cells were positively associated with their corresponding exhaustion states. Furthermore, the application of ICBs targeting effector CD4+ T cells in Module 1 (αPD-1) and Treg cells in Module 2 (αCTLA-4) in mouse models could help reinvigorate the effector function of Module 1-exhausted CD4+ T cells and reduce the immunosuppressive function of Module 2-exhausted CD4+ T cells, ultimately promoting OPSCC tumor regression. Taken together, our study provides a crucial cellular basis for the selection of optimal ICB in treating OPSCC.© 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验
第一作者:
第一作者机构: [1]Department of Oto-Rhino-Laryngology West China Hospital, Sichuan University Chengdu Sichuan China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Oto-Rhino-Laryngology West China Hospital, Sichuan University Chengdu Sichuan China. [4]West China Biomedical Big Data Center West China Hospital Sichuan University Chengdu Sichuan China. [*1]Department of Oto-Rhino-Laryngology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46420 今日访问量:0 总访问量:3323 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号